Loading…

P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2017-02, Vol.11 (suppl_1), p.S246-S246
Main Authors:	Gecse, K.B., Vegh, Z., Kurti, Z., Rutka, M., Farkas, K., Golovics, P.A., Lovasz, B.D., Gonczi, L., Banai, J., Bene, L., Gasztonyi, B., Kristof, T., Lakatos, L., Miheller, P., Nagy, F., Palatka, K., Papp, M., Patai, A., Salamon, A., Szamosi, T., Szepes, Z., Toth, G.T., Vincze, A., Molnar, T., Lakatos, P.L.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c1396-aa7cb169b4011af0bd2053315a962558ad4cbcf599fd46801d4c6d518d5629683
cites
container_end_page	S246
container_issue	suppl_1
container_start_page	S246
container_title	Journal of Crohn's and colitis
container_volume	11
creator	Gecse, K.B. Vegh, Z. Kurti, Z. Rutka, M. Farkas, K. Golovics, P.A. Lovasz, B.D. Gonczi, L. Banai, J. Bene, L. Gasztonyi, B. Kristof, T. Lakatos, L. Miheller, P. Nagy, F. Palatka, K. Papp, M. Patai, A. Salamon, A. Szamosi, T. Szepes, Z. Toth, G.T. Vincze, A. Molnar, T. Lakatos, P.L.
description
doi_str_mv	10.1093/ecco-jcc/jjx002.456
format	article
fullrecord	<record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ecco_jcc_jjx002_456</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ecco_jcc_jjx002_456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1396-aa7cb169b4011af0bd2053315a962558ad4cbcf599fd46801d4c6d518d5629683</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EEqXwBWz8A2nt-JGYHaooRaoEC1hbEz-EozSu7ADNil8npYjVnbuYq6OD0C0lC0oUWzpjYtEas2zbAyHlggt5hma0rmTBeaXOf29WKMXlJbrKuSVEKFHVM_T9whjF69BDh5PLH92Qceyx8z4YMCOG3uIM3g0jjh43IeawCx0kHHrfhUPYQYPBDy5NX64YHaS7_x2f4g4D3qeY984M4dPhHoYQ-69gHTbxPabhGl146LK7-cs5els_vK42xfb58Wl1vy0MZUoWAJVpqFQNJ5SCJ40tiZjIBShZClGD5aYxXijlLZc1oVOXVtDaClkqWbM5YqddM9Hk5Lzepwk-jZoSfXSojw715FCfHOrJIfsB7UZqNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort</title><source>Oxford Journals Online</source><creator>Gecse, K.B. ; Vegh, Z. ; Kurti, Z. ; Rutka, M. ; Farkas, K. ; Golovics, P.A. ; Lovasz, B.D. ; Gonczi, L. ; Banai, J. ; Bene, L. ; Gasztonyi, B. ; Kristof, T. ; Lakatos, L. ; Miheller, P. ; Nagy, F. ; Palatka, K. ; Papp, M. ; Patai, A. ; Salamon, A. ; Szamosi, T. ; Szepes, Z. ; Toth, G.T. ; Vincze, A. ; Molnar, T. ; Lakatos, P.L.</creator><creatorcontrib>Gecse, K.B. ; Vegh, Z. ; Kurti, Z. ; Rutka, M. ; Farkas, K. ; Golovics, P.A. ; Lovasz, B.D. ; Gonczi, L. ; Banai, J. ; Bene, L. ; Gasztonyi, B. ; Kristof, T. ; Lakatos, L. ; Miheller, P. ; Nagy, F. ; Palatka, K. ; Papp, M. ; Patai, A. ; Salamon, A. ; Szamosi, T. ; Szepes, Z. ; Toth, G.T. ; Vincze, A. ; Molnar, T. ; Lakatos, P.L.</creatorcontrib><identifier>ISSN: 1873-9946</identifier><identifier>EISSN: 1876-4479</identifier><identifier>DOI: 10.1093/ecco-jcc/jjx002.456</identifier><language>eng</language><ispartof>Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S246-S246</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1396-aa7cb169b4011af0bd2053315a962558ad4cbcf599fd46801d4c6d518d5629683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Gecse, K.B.</creatorcontrib><creatorcontrib>Vegh, Z.</creatorcontrib><creatorcontrib>Kurti, Z.</creatorcontrib><creatorcontrib>Rutka, M.</creatorcontrib><creatorcontrib>Farkas, K.</creatorcontrib><creatorcontrib>Golovics, P.A.</creatorcontrib><creatorcontrib>Lovasz, B.D.</creatorcontrib><creatorcontrib>Gonczi, L.</creatorcontrib><creatorcontrib>Banai, J.</creatorcontrib><creatorcontrib>Bene, L.</creatorcontrib><creatorcontrib>Gasztonyi, B.</creatorcontrib><creatorcontrib>Kristof, T.</creatorcontrib><creatorcontrib>Lakatos, L.</creatorcontrib><creatorcontrib>Miheller, P.</creatorcontrib><creatorcontrib>Nagy, F.</creatorcontrib><creatorcontrib>Palatka, K.</creatorcontrib><creatorcontrib>Papp, M.</creatorcontrib><creatorcontrib>Patai, A.</creatorcontrib><creatorcontrib>Salamon, A.</creatorcontrib><creatorcontrib>Szamosi, T.</creatorcontrib><creatorcontrib>Szepes, Z.</creatorcontrib><creatorcontrib>Toth, G.T.</creatorcontrib><creatorcontrib>Vincze, A.</creatorcontrib><creatorcontrib>Molnar, T.</creatorcontrib><creatorcontrib>Lakatos, P.L.</creatorcontrib><title>P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort</title><title>Journal of Crohn's and colitis</title><issn>1873-9946</issn><issn>1876-4479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRS0EEqXwBWz8A2nt-JGYHaooRaoEC1hbEz-EozSu7ADNil8npYjVnbuYq6OD0C0lC0oUWzpjYtEas2zbAyHlggt5hma0rmTBeaXOf29WKMXlJbrKuSVEKFHVM_T9whjF69BDh5PLH92Qceyx8z4YMCOG3uIM3g0jjh43IeawCx0kHHrfhUPYQYPBDy5NX64YHaS7_x2f4g4D3qeY984M4dPhHoYQ-69gHTbxPabhGl146LK7-cs5els_vK42xfb58Wl1vy0MZUoWAJVpqFQNJ5SCJ40tiZjIBShZClGD5aYxXijlLZc1oVOXVtDaClkqWbM5YqddM9Hk5Lzepwk-jZoSfXSojw715FCfHOrJIfsB7UZqNg</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Gecse, K.B.</creator><creator>Vegh, Z.</creator><creator>Kurti, Z.</creator><creator>Rutka, M.</creator><creator>Farkas, K.</creator><creator>Golovics, P.A.</creator><creator>Lovasz, B.D.</creator><creator>Gonczi, L.</creator><creator>Banai, J.</creator><creator>Bene, L.</creator><creator>Gasztonyi, B.</creator><creator>Kristof, T.</creator><creator>Lakatos, L.</creator><creator>Miheller, P.</creator><creator>Nagy, F.</creator><creator>Palatka, K.</creator><creator>Papp, M.</creator><creator>Patai, A.</creator><creator>Salamon, A.</creator><creator>Szamosi, T.</creator><creator>Szepes, Z.</creator><creator>Toth, G.T.</creator><creator>Vincze, A.</creator><creator>Molnar, T.</creator><creator>Lakatos, P.L.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20170201</creationdate><title>P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort</title><author>Gecse, K.B. ; Vegh, Z. ; Kurti, Z. ; Rutka, M. ; Farkas, K. ; Golovics, P.A. ; Lovasz, B.D. ; Gonczi, L. ; Banai, J. ; Bene, L. ; Gasztonyi, B. ; Kristof, T. ; Lakatos, L. ; Miheller, P. ; Nagy, F. ; Palatka, K. ; Papp, M. ; Patai, A. ; Salamon, A. ; Szamosi, T. ; Szepes, Z. ; Toth, G.T. ; Vincze, A. ; Molnar, T. ; Lakatos, P.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1396-aa7cb169b4011af0bd2053315a962558ad4cbcf599fd46801d4c6d518d5629683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gecse, K.B.</creatorcontrib><creatorcontrib>Vegh, Z.</creatorcontrib><creatorcontrib>Kurti, Z.</creatorcontrib><creatorcontrib>Rutka, M.</creatorcontrib><creatorcontrib>Farkas, K.</creatorcontrib><creatorcontrib>Golovics, P.A.</creatorcontrib><creatorcontrib>Lovasz, B.D.</creatorcontrib><creatorcontrib>Gonczi, L.</creatorcontrib><creatorcontrib>Banai, J.</creatorcontrib><creatorcontrib>Bene, L.</creatorcontrib><creatorcontrib>Gasztonyi, B.</creatorcontrib><creatorcontrib>Kristof, T.</creatorcontrib><creatorcontrib>Lakatos, L.</creatorcontrib><creatorcontrib>Miheller, P.</creatorcontrib><creatorcontrib>Nagy, F.</creatorcontrib><creatorcontrib>Palatka, K.</creatorcontrib><creatorcontrib>Papp, M.</creatorcontrib><creatorcontrib>Patai, A.</creatorcontrib><creatorcontrib>Salamon, A.</creatorcontrib><creatorcontrib>Szamosi, T.</creatorcontrib><creatorcontrib>Szepes, Z.</creatorcontrib><creatorcontrib>Toth, G.T.</creatorcontrib><creatorcontrib>Vincze, A.</creatorcontrib><creatorcontrib>Molnar, T.</creatorcontrib><creatorcontrib>Lakatos, P.L.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Crohn's and colitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gecse, K.B.</au><au>Vegh, Z.</au><au>Kurti, Z.</au><au>Rutka, M.</au><au>Farkas, K.</au><au>Golovics, P.A.</au><au>Lovasz, B.D.</au><au>Gonczi, L.</au><au>Banai, J.</au><au>Bene, L.</au><au>Gasztonyi, B.</au><au>Kristof, T.</au><au>Lakatos, L.</au><au>Miheller, P.</au><au>Nagy, F.</au><au>Palatka, K.</au><au>Papp, M.</au><au>Patai, A.</au><au>Salamon, A.</au><au>Szamosi, T.</au><au>Szepes, Z.</au><au>Toth, G.T.</au><au>Vincze, A.</au><au>Molnar, T.</au><au>Lakatos, P.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort</atitle><jtitle>Journal of Crohn's and colitis</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>11</volume><issue>suppl_1</issue><spage>S246</spage><epage>S246</epage><pages>S246-S246</pages><issn>1873-9946</issn><eissn>1876-4479</eissn><doi>10.1093/ecco-jcc/jjx002.456</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1873-9946
ispartof	Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S246-S246
issn	1873-9946 1876-4479
language	eng
recordid	cdi_crossref_primary_10_1093_ecco_jcc_jjx002_456
source	Oxford Journals Online
title	P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A24%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P331%20Final%20results%20on%20efficacy%20and%20safety%20of%20biosimilar%20infliximab%20after%20one-year:%20results%20from%20a%20prospective%20nationwide%20cohort&rft.jtitle=Journal%20of%20Crohn's%20and%20colitis&rft.au=Gecse,%20K.B.&rft.date=2017-02-01&rft.volume=11&rft.issue=suppl_1&rft.spage=S246&rft.epage=S246&rft.pages=S246-S246&rft.issn=1873-9946&rft.eissn=1876-4479&rft_id=info:doi/10.1093/ecco-jcc/jjx002.456&rft_dat=%3Ccrossref%3E10_1093_ecco_jcc_jjx002_456%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1396-aa7cb169b4011af0bd2053315a962558ad4cbcf599fd46801d4c6d518d5629683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true